Pages without language links
Jump to navigation
Jump to search
The following pages do not link to other language versions.
Showing below up to 50 results in range #1 to #50.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
- ASCO guidelines
- Abarelix (Plenaxis)
- Abciximab (ReoPro)
- Abemaciclib (Verzenio)
- Abexinostat (PCI-24781)
- Abiraterone (Zytiga)
- Academic Medicine exhibit
- Academic Medicine standard narrative
- Academic Medicine wiki-based narrative
- Acalabrutinib (Calquence)
- Acetaminophen (Tylenol)
- Acetazolamide (Diamox)
- Aclarubicin (Aclacinon)
- Acquired hemophilia A
- Acquired thrombotic thrombocytopenic purpura
- Actinium Ac 225 lintuzumab (Actimab-A)
- Acute lymphoblastic leukemia, infant
- Acute lymphoblastic leukemia, infant - historical
- Acute myeloid leukemia
- Acute myeloid leukemia, FLT3-positive
- Acute myeloid leukemia, FLT3-positive - null regimens
- Acute myeloid leukemia, IDH-mutated
- Acute myeloid leukemia, NPM1-mutated
- Acute myeloid leukemia, pediatric
- Acute myeloid leukemia, pediatric - historical
- Acute myeloid leukemia - historical
- Acute myeloid leukemia - null regimens
- Acute myeloid leukemia trial demographics
- Acute promyelocytic leukemia
- Acute promyelocytic leukemia - null regimens
- Acyclovir (Zovirax)
- Adagrasib (Krazati)
- Adavosertib (MK-1775)
- Adebrelimab (SHR-1316)
- Adrenocortical carcinoma
- Adrenocortical carcinoma - null regimens
- Adult T-cell leukemia-lymphoma
- Adult T-cell leukemia-lymphoma - historical
- Afamitresgene Autoleucel (ADP-A2M4)
- Afatinib (Gilotrif)
- Afuresertib (GSK-2110183)
- Agatolimod (PF-3512676)
- Aggressive Non-Hodgkin lymphoma
- Aldesleukin (Proleukin)
- Alectinib (Alecensa)
- Alemtuzumab (Campath)
- Alendronate (Fosamax)
- Alisertib (MLN-8237)
- Alitretinoin (Panretin)
- Alizapride (Litican)